Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Cleveland Biolabs, Inc. > News item |
Cleveland BioLabs extends expiration date of its series D warrants
Warrants will now expire March 30, 2018
By Devika Patel
Knoxville, Tenn., Oct. 2 – Cleveland BioLabs, Inc. revised its series D warrants on Sept. 29, according to an 8-K filed Thursday with the Securities and Exchange Commission.
The warrant expiration date has been extended to March 30, 2018 from Feb. 13, 2016.
Based in Buffalo, Cleveland BioLabs develops treatments for cancer.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.